Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2013
To examine the safety and efficacy of tofacitinib in subjects with active psoriatic arthritis who have previously had an inadequate response to at least one TNF inhibitor either due to lack of efficacy or an adverse event.
Epistemonikos ID: e34ead90eda4f264342830157ce87e70485e870b
First added on: Feb 15, 2022